BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 21565324)

  • 1. Effect of pioglitazone on endothelial dysfunction after sirolimus-eluting stent implantation.
    Kitahara H; Kobayashi Y; Iwata Y; Fujimoto Y; Komuro I
    Am J Cardiol; 2011 Jul; 108(2):214-9. PubMed ID: 21565324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of stem cell mobilization by granulocyte colony-stimulating factor on endothelial function after sirolimus-eluting stent implantation: a double-blind, randomized, placebo-controlled clinical trial.
    Iwata Y; Fujimoto Y; Morino T; Sugimoto K; Ohkubo K; Kadohira T; Fukushima K; Kitahara H; Komuro I; Kobayashi Y
    Am Heart J; 2013 Mar; 165(3):408-14. PubMed ID: 23453111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus- versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction.
    Kim JW; Seo HS; Park JH; Na JO; Choi CU; Lim HE; Kim EJ; Rha SW; Park CG; Oh DJ
    J Am Coll Cardiol; 2009 May; 53(18):1653-9. PubMed ID: 19406340
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction.
    Togni M; Windecker S; Cocchia R; Wenaweser P; Cook S; Billinger M; Meier B; Hess OM
    J Am Coll Cardiol; 2005 Jul; 46(2):231-6. PubMed ID: 16022947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sirolimus-eluting stent implantation aggravates endothelial vasomotor dysfunction in the infarct-related coronary artery in patients with acute myocardial infarction.
    Obata JE; Kitta Y; Takano H; Kodama Y; Nakamura T; Mende A; Kawabata K; Saitoh Y; Fujioka D; Kobayashi T; Yano T; Kugiyama K
    J Am Coll Cardiol; 2007 Oct; 50(14):1305-9. PubMed ID: 17903627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery of endothelial function after sirolimus-eluting stent implantation: a pilot study.
    Kitahara H; Fujimoto Y; Ishikawa K; Aoki Y; Iwata Y; Kadohira T; Morino T; Ohkubo K; Sugimoto K; Kobayashi Y
    Angiology; 2013 Apr; 64(3):211-5. PubMed ID: 22523131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired endothelial vasomotor function after sirolimus-eluting stent implantation.
    Fuke S; Maekawa K; Kawamoto K; Saito H; Sato T; Hioka T; Ohe T
    Circ J; 2007 Feb; 71(2):220-5. PubMed ID: 17251671
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation.
    Hofma SH; van der Giessen WJ; van Dalen BM; Lemos PA; McFadden EP; Sianos G; Ligthart JM; van Essen D; de Feyter PJ; Serruys PW
    Eur Heart J; 2006 Jan; 27(2):166-70. PubMed ID: 16249221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective effect of telmisartan against endothelial dysfunction after coronary drug-eluting stent implantation in hypertensive patients.
    Terashima M; Kaneda H; Nasu K; Matsuo H; Habara M; Ito T; Tanaka N; Rathore S; Kinoshita Y; Kimura M; Ehara M; Suzuki Y; Suzuki T
    JACC Cardiovasc Interv; 2012 Feb; 5(2):182-90. PubMed ID: 22361603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute myocardial infarction with sirolimus-eluting stents results in chronic endothelial dysfunction in the infarct-related coronary artery.
    Obata JE; Nakamura T; Kitta Y; Kodama Y; Sano K; Kawabata K; Saitoh Y; Fujioka D; Kobayashi T; Yano T; Watanabe Y; Watanabe K; Kugiyama K
    Circ Cardiovasc Interv; 2009 Oct; 2(5):384-91. PubMed ID: 20031747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Firebird and cypher sirolimus-eluting stents and bare metal stents in treatment of very long coronary lesions.
    Fan L; Chen LL; Lin CG; Peng YF; Zheng XC; Luo YK; Zhang FL; Chen JH; Yan XP; Huang ZR
    Chin Med J (Engl); 2008 Aug; 121(16):1518-23. PubMed ID: 18982862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary endothelial dysfunction distal to stent of first-generation drug-eluting stents.
    Mitsutake Y; Ueno T; Yokoyama S; Sasaki K; Sugi Y; Toyama Y; Koiwaya H; Ohtsuka M; Nakayoshi T; Itaya N; Chibana H; Kakuma T; Imaizumi T
    JACC Cardiovasc Interv; 2012 Sep; 5(9):966-73. PubMed ID: 22995884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term clinical benefit of sirolimus-eluting stent implantation in diabetic patients with de novo coronary stenoses: long-term results of the DIABETES trial.
    Jiménez-Quevedo P; Sabaté M; Angiolillo DJ; Alfonso F; Hernández-Antolín R; SanMartín M; Gómez-Hospital JA; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Eur Heart J; 2007 Aug; 28(16):1946-52. PubMed ID: 17562666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug-eluting stent implantation could be associated with long-term coronary endothelial dysfunction.
    Shin DI; Kim PJ; Seung KB; Kim DB; Kim MJ; Chang K; Lim SM; Jeon DS; Chung WS; Baek SH; Lee MY
    Int Heart J; 2007 Sep; 48(5):553-67. PubMed ID: 17998765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors predictive of cardiac events and restenosis after sirolimus-eluting stent implantation in small coronary arteries.
    Lee CW; Suh J; Lee SW; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
    Catheter Cardiovasc Interv; 2007 May; 69(6):821-5. PubMed ID: 17191211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term coronary endothelial function after zotarolimus-eluting stent implantation. A 9 month comparison between zotarolimus-eluting and sirolimus-eluting stents.
    Shin DI; Seung KB; Kim PJ; Chang K; Choi JK; Jeon DS; Kim MJ; Lee MY; Chung WS
    Int Heart J; 2008 Nov; 49(6):639-52. PubMed ID: 19075480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effect of angiotensin II receptor blocker and calcium channel blocker on endothelial vasomotor function after everolimus-eluting stent implantation.
    Aoki Y; Ishikawa K; Miura K; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
    J Cardiol; 2016 Mar; 67(3):236-40. PubMed ID: 26194867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term clinical benefit of sirolimus-eluting stents in patients with in-stent restenosis results of the RIBS-II (Restenosis Intra-stent: Balloon angioplasty vs. elective sirolimus-eluting Stenting) study.
    Alfonso F; Pérez-Vizcayno MJ; Hernández R; Bethencourt A; Martí V; López-Mínguez JR; Angel J; Iñiguez A; Morís C; Cequier A; Sabaté M; Escaned J; Jiménez-Quevedo P; Bañuelos C; Suárez A; Macaya C;
    J Am Coll Cardiol; 2008 Nov; 52(20):1621-7. PubMed ID: 18992651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candesartan with pioglitazone protects against endothelial dysfunction and inflammatory responses in porcine coronary arteries implanted with sirolimus-eluting stents.
    Dohi T; Miyauchi K; Iesaki T; Tsuruta R; Tsuboi S; Ogita M; Kubota N; Kasai T; Yokoyama T; Daida H
    Circ J; 2011; 75(5):1098-106. PubMed ID: 21383515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intractable Prinzmetal's angina three months after implantation of sirolimus-eluting stent.
    Abe M; Yoshida A; Otsuka Y
    J Invasive Cardiol; 2008 Nov; 20(11):E306-9. PubMed ID: 18987406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.